(Q37273304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

Recent advances in p53 research: an interdisciplinary perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Pierre Hainaut

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

M Olivier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Petitjean

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Pétré

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Mounawar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Plymoth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

C C de Fromentel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

19 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802452%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2008.69

14 January 2020

exact match

0 references

cites work

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Functional evolution of the p53 regulatory network through its target response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

p53: new roles in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Contribution of membrane localization to the apoptotic activity of PUMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Inflammation and cancer: an ancient link with novel potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Regulation of Cdc42-mediated morphological effects: a novel function for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Structural basis for understanding oncogenic p53 mutations and designing rescue drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Core domain interactions in full-length p53 in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Tumor-derived p53 mutants induce NF-kappaB2 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Inactivation of the p53 pathway in retinoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

PML enhances the regulation of p53 by CK1 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

A twist for survival and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

p53 isoforms can regulate p53 transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

DNA damage signalling guards against activated oncogenes and tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

p53 therapy in a patient with Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

inferred from DOI database lookup

7 January 2021

based on heuristic

Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69

inferred from DOI database lookup

7 January 2021

based on heuristic

Reactivation of mutant p53: molecular mechanisms and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.69